Keith McCrae, MD

University Hospitals of ClevelandCleveland, Ohio - 44106 University Hospital of ClevelandCleveland, Ohio - 44106 (216-844-5413) |
- CLINICAL TRIALS 2
- CONDITIONS1
- INTERVENTIONS2
- SINCE2006

Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
June 2006 - October 2014

Rituximab to Treat Severe Hemophilia A
June 2006 - December 2011
Hemophilia A
Rituximab
Recombinant Protein-Free Factor Viii (Rahf-Pfm)



